Jean Clairambault

Follow

Generating author description...

All published works
Action Title Year Authors
+ Phenotype divergence and cooperation in isogenic multicellularity and in cancer 2024 Frank Ernesto Alvarez
Jean Clairambault
+ Mathematical Modelling of Cancer Growth and Drug Treatments: Taking Into Account Cell Population Heterogeneity and Plasticity 2023 Jean Clairambault
+ Supplementary Material, Tables S1-S2 and Figures S1-S7 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Data from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Supplementary Movie 3 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Supplementary Movie 2 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Data from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Supplementary Material, Tables S1-S2 and Figures S1-S7 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Supplementary Movie 3 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Supplementary Movie 2 from Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2023 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ A phenotype-structured model for the tumour-immune response 2023 Zineb Kaid
Camille Pouchol
Jean Clairambault
+ Phenotype divergence and cooperation in isogenic multicellularity and in cancer 2023 Frank Ernesto Alvarez
Jean Clairambault
+ PDF Chat Evolution of a structured cell population endowed with plasticity of traits under constraints on and between the traits 2022 Frank Ernesto Alvarez
José A. Carrillo
Jean Clairambault
+ PDF Chat Perspectives in cancer treatment 2022 Maxim Kuznetsov
Jean Clairambault
Vitaly Volpert
+ PDF Chat Perspectives in cancer treatment. Reply to comments on "Improving cancer treatments via dynamical biophysical models" 2022 Maxim Kuznetsov
Jean Clairambault
Vitali Volpert
+ PDF Chat Improving cancer treatments via dynamical biophysical models 2021 Maxim Kuznetsov
Jean Clairambault
Vitaly Volpert
+ PDF Chat Faculty Opinions recommendation of Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells. 2020 Jean Clairambault
+ PDF Chat Plasticity in Cancer Cell Populations: Biology, Mathematics and Philosophy of Cancer 2020 Jean Clairambault
+ PDF Chat A survey of adaptive cell population dynamics models of emergence of drug resistance in cancer, and open questions about evolution and cancer 2019 Jean Clairambault
Camille Pouchol
+ Adaptive dynamics of hematopoietic stem cells and their supporting stroma: a model and mathematical analysis 2019 Nguyen Thanh Hoai Nam
Jean Clairambault
Thierry Jaffredo
Benoı̂t Perthame
Delphine Salort
+ PDF Chat An Evolutionary Perspective on Cancer, with Applications to Anticancer Drug Resistance Modelling and Perspectives in Therapeutic Control 2019 Jean Clairambault
+ PDF Chat Introducing Cell-Plasticity Mechanisms into a Class of Cell Population Dynamical Systems 2018 Walid Djema
Catherine Bonnet
Frédéric Mazenc
Jean Clairambault
+ PDF Chat Stability Analysis of a Nonlinear System with Infinite Distributed Delays Describing Cell Dynamics 2018 Walid Djema
Frédéric Mazenc
Catherine Bonnet
Jean Clairambault
Emilia Fridman
+ PDF Chat Control in dormancy or eradication of cancer stem cells: Mathematical modeling and stability issues 2018 Walid Djema
Catherine Bonnet
Frédéric Mazenc
Jean Clairambault
Emilia Fridman
Pierre Hirsch
François Delhommeau
+ PDF Chat Analysis of a System Describing Proliferative-Quiescent Cell Dynamics 2018 Jean Clairambault
Benoı̂t Perthame
Andrada Quillas Maran
+ Why Is Evolution Important in Cancer and What Mathematics Should Be Used to Treat Cancer? Focus on Drug Resistance 2018 Luís Almeida
Rebecca H. Chisholm
Jean Clairambault
Tommaso Lorenzi
Alexander Lorz
Camille Pouchol
Emmanuel Trélat
+ Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy 2017 Camille Pouchol
Jean Clairambault
Alexander Lorz
Emmanuel Trélat
+ Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 2: from Theoretical Biology to Mathematical Models 2017 Aaron Goldman
Mohammad Kohandel
Jean Clairambault
+ Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer. Part 1: Biological Facts and Studies in Drug Resistance 2017 Aaron Goldman
Mohammad Kohandel
Jean Clairambault
+ PDF Chat Analysis of a model of dormancy in cancer as a state of coexistence between tumor and healthy stem cells 2017 Walid Djema
Catherine Bonnet
Jean Clairambault
Frédéric Mazenc
Pierre Hirsch
François Delhommeau
+ PDF Chat Stability of a delay system coupled to a differential-difference system describing the coexistence of ordinary and mutated hematopoietic stem cells 2016 Walid Djema
Frédéric Mazenc
Catherine Bonnet
Jean Clairambault
Pierre Hirsch
François Delhommeau
+ PDF Chat Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations 2016 Tommaso Lorenzi
Rebecca H. Chisholm
Jean Clairambault
+ Tumour growth and drug resistance: an evolutionary view with perspectives in therapeutics 2016 Jean Clairambault
Luís Almeida
Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Benoı̂t Perthame
Camille Pouchol
Emmanuel Trélat
+ PDF Chat Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation 2016 Rebecca H. Chisholm
Tommaso Lorenzi
Jean Clairambault
+ PDF Chat Physiologically Structured Cell Population Dynamic Models with Applications to Combined Drug Delivery Optimisation in Oncology 2016 Jean Clairambault
Olivier Fercoq
+ Preface of the “Symposium on Mathematical Models and Methods to investigate Heterogeneity in Cell and Cell Population Biology” 2016 Jean Clairambault
+ PDF Chat Phenotype heterogeneity in cancer cell populations 2016 Luís Almeida
Rebecca H. Chisholm
Jean Clairambault
Alexandre E. Escargueil
Tommaso Lorenzi
Alexander Lorz
Emmanuel Trélat
+ Emergence of cytotoxic resistance in cancer cell populations: Single-cell mechanisms and population-level consequences 2016 Tommaso Lorenzi
Rebecca H. Chisholm
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ PDF Chat Mathematics of Pharmacokinetics and Pharmacodynamics: Diversity of Topics, Models and Methods 2016 Gennady Bocharov
Anass Bouchnita
Jean Clairambault
Vitaly Volpert
+ Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy 2016 Camille Pouchol
Jean Clairambault
Alexander Lorz
Emmanuel Trélat
+ PDF Chat Preface to Session 70 " Mathematical models and methods to investigate heterogeneity in cell and cell population biology " 2015 Loïc Barbarroux
Jean Clairambault
N. G. Cogan
J. E. Elias
Shalla Hanson
Marek Kimmel
Tommaso Lorenzi
+ Phenotype heterogeneity in cancer cell populations 2015 Luís Almeida
Rebecca H. Chisholm
Jean Clairambault
Alexandre E. Escargueil
Tommaso Lorenzi
Alexander Lorz
Emmanuel Trélat
+ Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2015 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ PDF Chat Emergence of cytotoxic resistance in cancer cell populations* 2015 Tommaso Lorenzi
Rebecca H. Chisholm
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
+ Modeling the Effects of Space Structure and Combination Therapies on Phenotypic Heterogeneity and Drug Resistance in Solid Tumors 2014 Alexander Lorz
Tommaso Lorenzi
Jean Clairambault
Alexandre E. Escargueil
Benoı̂t Perthame
+ PDF Chat Enabling multiscale modeling in systems medicine: From reactions in cells to organ physiology 2014 Olaf Wolkenhauer
Charles Auffray
Olivier Brass
Jean Clairambault
Andreas Deutsch
Dirk Drasdo
Francesco Luigi Gervasio
Luigi Preziosi
Philip K. Maini
Anna Marciniak‐Czochra
+ Deterministic Mathematical Modelling for Cancer Chronotherapeutics: Cell Population Dynamics and Treatment Optimization 2014 Jean Clairambault
+ PDF Chat Deterministic mathematical modelling for cancer chronotherapeutics: cell population dynamics and treatment optimisation 2013 Jean Clairambault
+ Effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors 2013 Alexander Lorz
Tommaso Lorenzi
Jean Clairambault
Alexandre E. Escargueil
Benoı̂t Perthame
+ PDF Chat Designing proliferating cell population models with functional targets for control by anti-cancer drugs 2013 Frédérique Billy
Jean Clairambault
+ Pharmacokinetic Modeling 2013 Jean Clairambault
+ Age-structured cell population model to study the influence of growth factors on cell cycle dynamics 2012 Frédérique Billy
Jean Clairambault
Franck Delaunay
Céline Feillet
Natalia Robert
+ PDF Chat Applying ecological and evolutionary theory to cancer: a long and winding road 2012 Frédéric Thomas
Daniel Fisher
Philippe Fort
Jean‐Pierre Marie
Simon P. Daoust
Benjamín Roche
Christoph Grunau
Céline Cosseau
Guillaume Mitta
Stephen Baghdiguian
+ PDF Chat Optimisation of Cancer Drug Treatments Using Cell Population Dynamics 2012 Frédérique Billy
Jean Clairambault
Olivier Fercoq
+ PDF Chat Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies 2012 Alexander Lorz
Tommaso Lorenzi
Michael Hochberg
Jean Clairambault
Benoı̂t Perthame
+ Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies 2012 Alexander Lorz
Tommaso Lorenzi
Michael Hochberg
Jean Clairambault
Benoı̂t Perthame
+ PDF Chat Can theorems help treat cancer? 2012 Jean Clairambault
+ PDF Chat Modelling targets for anticancer drug control optimization in physiologically structured cell population models 2012 Frédérique Billy
Jean Clairambault
Olivier Fercoq
Tommaso Lorenzi
Alexander Lorz
Benoı̂t Perthame
+ Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies 2012 Alexander Lorz
Tommaso Lorenzi
Michael Hochberg
Jean Clairambault
Benoı̂t Perthame
+ PDF Chat Local Asymptotic Stability Conditions for the Positive Equilibrium of a System Modeling Cell Dynamics in Leukemia 2012 Hitay Özbay
Catherine Bonnet
Houda Benjelloun
Jean Clairambault
+ Optimizing cancer pharmacotherapeutics using mathematical modeling and a systems biology approach 2011 Jean Clairambault
+ Proliferation in Cell Population Models with Age Structure 2011 Frédérique Billy
Jean Clairambault
Olivier Fercoq
Stéphane Gaubert
Thomas Lepoutre
Thomas Ouillon
Theodore E. Simos
George Psihoyios
Ch. Tsitouras
Zacharias Anastassi
+ Modélisation biomédicale : Vers une médecine personnalisée 2010 Jean Clairambault
+ PDF Chat Circadian rhythm and cell population growth 2010 Jean Clairambault
Stéphane Gaubert
Thomas Lepoutre
+ Modelling the spatial organization of cell proliferation in the developing central nervous system 2010 Jean Clairambault
Vladimir Flores
Benoı̂t Perthame
Melina Rapacioli
Edmundo Rofman
Rafael Verdes
+ Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics 2009 Jean‐Louis Steimer
Svein G. Dahl
Dinesh P. de Alwis
Ursula Gundert‐Remy
Mats O. Karlsson
Jiřina Martı́nková
Leon Aarons
Hans-Jürgen Ahr
Jean Clairambault
Gilles Freyer
+ PDF Chat Faculty Opinions recommendation of Dynamics and potential impact of the immune response to chronic myelogenous leukemia. 2009 Jean Clairambault
+ PDF Chat Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments 2009 Jean Clairambault
+ PDF Chat Comparison of Perron and Floquet Eigenvalues in Age Structured Cell Division Cycle Models 2009 Jean Clairambault
Stéphane Gaubert
Thomas Lepoutre
+ Modélisation de la dynamique de l'hématopoïèse normale et pathologique Modelling the dynamics of normal and pathological haematopoiesis 2008 Mostafa Adimy
Samuel Bernard
Jean Clairambault
Fabien Crauste
Stéphane Génieys
Laurent Pujo-Menjouet
+ PDF Chat An inequality for the Perron and Floquet eigenvalues of monotone differential systems and age structured equations 2007 Jean Clairambault
Stéphane Gaubert
Benoı̂t Perthame
+ Analysis of a molecular structured population model with possible polynomial growth for the cell division cycle 2007 Fadia Bekkal Brikci
Jean Clairambault
Benoı̂t Perthame
+ Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance 2007 Jean Clairambault
+ A Mathematical Model of the Cell Cycle and Its Circadian Control 2007 Jean Clairambault
Philippe Michel
Benoı̂t Perthame
+ PDF Chat Circadian rhythm and tumour growth 2006 Jean Clairambault
Philippe Michel
Benoı̂t Perthame
+ New Results - Autres applications de la théorie de Perron-Frobenius non-linéaire/Other applications of non-linear Perron-Frobenius theory 2006 Marianne Akian
Stéphane Gaubert
Laure Ninove
Jean Clairambault
Benoı̂t Perthame
Edurne Seijo
+ An age-and-cyclin-structured cell population model with proliferation and quiescence for healthy and tumoral tissues 2006 Fadia Bekkal Brikci
Jean Clairambault
Benjamin Ribba
Benoı̂t Perthame
+ Rythme circadien et croissance tumorale 2006 Jean Clairambault
Philippe Michel
Benoı̂t Perthame
+ PDF Chat Circadian rhythm and tumour growth 2005 Jean Clairambault
Philippe Michel
Benoı̂t Perthame
+ PDF Chat Optimisation of time-scheduled regimen for anti-cancer drug infusion 2005 Claude Basdevant
Jean Clairambault
Françis Lévi
+ Optimal drug infusion strategies for cancer chronotherapy 2004 Claude Basdevant
Jean Clairambault
Françis Lévi
+ Toxicité et efficacité antitumorale de l'oxaliplatine sur l'ostéosarcome de Glasgow induit chez la souris : un modèle mathématique 2003 Jean Clairambault
Claude Daniel
Elisabeth Filipski
Teresa Granda
Françis Lévi
+ A mathematical model of the cell cycle and its control 2003 Jean Clairambault
Béatrice Laroche
Stéphane Mischler
Benoı̂t Perthame
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Transport Equations in Biology 2006 Benoı̂t Perthame
23
+ PDF Chat Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies 2012 Alexander Lorz
Tommaso Lorenzi
Michael Hochberg
Jean Clairambault
Benoı̂t Perthame
21
+ Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation 2015 Rebecca H. Chisholm
Tommaso Lorenzi
Alexander Lorz
Annette K. Larsen
Luís Almeida
Alexandre E. Escargueil
Jean Clairambault
14
+ PDF Chat Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation 2016 Rebecca H. Chisholm
Tommaso Lorenzi
Jean Clairambault
11
+ Modeling the Effects of Space Structure and Combination Therapies on Phenotypic Heterogeneity and Drug Resistance in Solid Tumors 2014 Alexander Lorz
Tommaso Lorenzi
Jean Clairambault
Alexandre E. Escargueil
Benoı̂t Perthame
11
+ A survey of structured cell population dynamics 1995 Ovide Arino
10
+ A nonlinear structured population model of tumor growth with quiescence 1990 Mats Gyllenberg
Glenn F. Webb
10
+ PDF Chat Optimisation of time-scheduled regimen for anti-cancer drug infusion 2005 Claude Basdevant
Jean Clairambault
Françis Lévi
10
+ PDF Chat Non-Darwinian dynamics in therapy-induced cancer drug resistance 2013 Angela Oliveira Pisco
Amy Brock
Joseph Zhou
Andreas E. Moor
Mitra Mojtahedi
Dean A. Jackson
Sui Huang
10
+ PDF Chat Circadian rhythm and tumour growth 2006 Jean Clairambault
Philippe Michel
Benoı̂t Perthame
10
+ PDF Chat Synchronisation and control of proliferation in cycling cell population models with age structure 2012 Frédérique Billy
Jean Clairambaultt
Olivier Fercoq
Stéphane Gaubertt
Thomas Lepoutre
Thomas Ouillon
Shoko Saito
10
+ Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance 2007 Jean Clairambault
9
+ A mathematical model of the cell cycle and its control 2003 Jean Clairambault
Béatrice Laroche
Stéphane Mischler
Benoı̂t Perthame
9
+ Analysis of a molecular structured population model with possible polynomial growth for the cell division cycle 2007 Fadia Bekkal Brikci
Jean Clairambault
Benoı̂t Perthame
9
+ PDF Chat Circadian rhythm and tumour growth 2005 Jean Clairambault
Philippe Michel
Benoı̂t Perthame
9
+ PDF Chat Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments 2009 Jean Clairambault
9
+ General relative entropy inequality: an illustration on growth models 2005 Philippe Michel
Stéphane Mischler
Benoı̂t Perthame
8
+ PDF Chat The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance 2013 Orit Lavi
James M. Greene
Doron Levy
Michael M. Gottesman
8
+ Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy 2017 Camille Pouchol
Jean Clairambault
Alexander Lorz
Emmanuel Trélat
8
+ A mathematical model for analysis of the cell cycle in cell lines derived from human tumors 2003 Britta Basse
Bruce C. Baguley
Elaine S. Marshall
Wayne R. Joseph
Bruce van Brunt
G.C. Wake
David J. N. Wall
7
+ PDF Chat Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations 2016 Tommaso Lorenzi
Rebecca H. Chisholm
Jean Clairambault
7
+ Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling 2008 Atilla Altinok
Françis Lévi
Albert Goldbeter
7
+ Age-structured cell population model to study the influence of growth factors on cell cycle dynamics 2012 Frédérique Billy
Jean Clairambault
Franck Delaunay
Céline Feillet
Natalia Robert
7
+ PDF Chat A theoretical quantitative model for evolution of cancer chemotherapy resistance 2010 Ariosto S. Silva
Robert A. Gatenby
7
+ PDF Chat Analysis of a Population Model Structured by the Cells Molecular Content 2007 Marie Doumic
7
+ PDF Chat Optimisation of Cancer Drug Treatments Using Cell Population Dynamics 2012 Frédérique Billy
Jean Clairambault
Olivier Fercoq
7
+ Control Theory Approach to Cancer Chemotherapy: Benefiting from Phase Dependence and Overcoming Drug Resistance 2005 Marek Kimmel
Andrzej Świerniak
7
+ Adaptive Therapy 2009 Robert A. Gatenby
Ariosto S. Silva
Robert J. Gillies
B. Roy Frieden
7
+ PDF Chat The contribution of age structure to cell population responses to targeted therapeutics 2012 Pierre Gabriel
Shawn Garbett
Vito Quaranta
Darren R. Tyson
Glenn F. Webb
6
+ PDF Chat Designing proliferating cell population models with functional targets for control by anti-cancer drugs 2013 Frédérique Billy
Jean Clairambault
6
+ PDF Chat Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells 2011 Piyush B. Gupta
Christine M. Fillmore
Guozhi Jiang
Sagi Shapira
Kai Tao
Charlotte Kuperwasser
Eric S. Lander
6
+ PDF Chat Dirac Mass Dynamics in Multidimensional Nonlocal Parabolic Equations 2011 Alexander Lorz
Sepideh Mirrahimi
Benoı̂t Perthame
6
+ Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. 1999 Philip Hahnfeldt
Dipak Panigrahy
Judah Folkman
Lynn Hlatky
6
+ Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment 2006 Alexander R.A. Anderson
Alissa M. Weaver
Peter T. Cummings
Vito Quaranta
6
+ PDF Chat An inequality for the Perron and Floquet eigenvalues of monotone differential systems and age structured equations 2007 Jean Clairambault
Stéphane Gaubert
Benoı̂t Perthame
6
+ PDF Chat Comparison of Perron and Floquet Eigenvalues in Age Structured Cell Division Cycle Models 2009 Jean Clairambault
Stéphane Gaubert
Thomas Lepoutre
6
+ Individual-based and continuum models of growing cell populations: a comparison 2008 Helen M. Byrne
Dirk Drasdo
6
+ Evolutionary dynamics of carcinogenesis and why targeted therapy does not work 2012 Robert J. Gillies
Daniel Verduzco
Robert A. Gatenby
6
+ Comparison of Approaches to Modeling of Cell Population Dynamics 1993 Ovide Arino
Marek Kimmel
6
+ PDF Chat Circadian rhythm and cell population growth 2010 Jean Clairambault
Stéphane Gaubert
Thomas Lepoutre
6
+ Quiescence as an explanation of Gompertzian tumor growth. 1989 Mats Gyllenberg
G F Webb
5
+ PDF Chat STABILITY IN A NONLINEAR POPULATION MATURATION MODEL 2002 Stéphane Mischler
Benoı̂t Perthame
Lenya Ryzhik
5
+ PDF Chat Gene Expression Noise Facilitates Adaptation and Drug Resistance Independently of Mutation 2011 Daniel A. Charlebois
Nezar Abdennur
Mads Kærn
5
+ A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomas 2003 John C. Panetta
Mark N. Kirstein
Amar Gajjar
GLakhsmi Nair
Maryam Fouladi
Clinton F. Stewart
5
+ An elementary approach to modeling drug resistance in cancer 2010 Cristian Tomasetti
Doron Levy
5
+ PDF Chat Resonance phenomena in cell population chemotherapy models 1990 Glenn F. Webb
5
+ A cell cycle automaton model for probing circadian patterns of anticancer drug delivery 2007 Atilla Altinok
Françis Lévi
Albert Goldbeter
5
+ Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK–PD model 2001 Dominique Barbolosi
Athanassios Iliadis
5
+ A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy 2000 Trachette L. Jackson
Helen M. Byrne
5
+ Desynchronization Rate in Cell Populations: Mathematical Modeling and Experimental Data 2001 Giovanna Chiorino
J. A. J. Metz
Daniela Tomasoni
Paolo Ubezio
5